MedPath

Phentermine Hydrochloride

Generic Name
Phentermine Hydrochloride

Overview

No overview information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Rebel Distributors Corp
21695-510
ORAL
30 mg in 1 1
2/7/2008
Unit Dose Services
50436-3175
ORAL
30 mg in 1 1
12/20/2018
Unit Dose Services
50436-6760
ORAL
30 mg in 1 1
10/23/2017
Blenheim Pharmacal, Inc.
10544-592
ORAL
37.5 mg in 1 1
5/24/2013
Direct_Rx
61919-865
ORAL
30 mg in 1 1
4/12/2023
Blenheim Pharmacal, Inc.
10544-552
ORAL
30 mg in 1 1
3/30/2015
Bryant Ranch Prepack
71335-0419
ORAL
15 mg in 1 1
5/31/2019
DIRECT RX
61919-244
ORAL
30 mg in 1 1
7/11/2016
Life Line Home Care Services, Inc.
75921-025
ORAL
37.5 mg in 1 1
3/8/2012
Physicians Total Care, Inc.
54868-6290
ORAL
37.5 mg in 1 1
6/4/2012

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
JUNOMINE ER phentermine (as hydrochloride) 40 mg extended release tablet blister pack
309917
Juno PC Holdings Pty Limited
Medicine
A
1/9/2020
ALENAMI phentermine (as hydrochloride) 40 mg sustained release capsule blister pack
319420
Medicine
A
2/25/2021
JUNOPHEN ER phentermine (as hydrochloride) 30 mg extended release tablet blister pack
344060
Juno PC Holdings Pty Limited
Medicine
A
10/20/2021
SUPREMINE ER phentermine (as hydrochloride) 40 mg extended release tablet blister pack
344058
Juno PC Holdings Pty Limited
Medicine
A
10/20/2021
NOVAPHEN phentermine (as hydrochloride) 30 mg modified release capsule blister pack
375861
Medicine
A
2/17/2023
PHENTERMINE SANDOZ phentermine (as hydrochloride) 40 mg sustained release capsule blister pack
379013
Medicine
A
3/11/2022
PHENTERMINE ARW phentermine (as hydrochloride) 30 mg modified release capsule blister pack
310864
Medicine
A
8/11/2021
PHENTERMINE GPPL phentermine (as hydrochloride) 30 mg modified release capsule blister pack
310862
Medicine
A
8/11/2021
PHENTERMINE JUNO ER phentermine (as hydrochloride) 15 mg extended release tablet blister pack
309879
Juno PC Holdings Pty Limited
Medicine
A
1/9/2020
PHENTERMINE JUNO ER phentermine (as hydrochloride) 30 mg extended release tablet blister pack
309909
Juno PC Holdings Pty Limited
Medicine
A
1/9/2020

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
FASTIN CAP 30MG
smithkline beecham pharma division of smithkline beecham inc
01916831
Capsule - Oral
30 MG / CAP
12/31/1993

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.